Pathophysiology • GI and Hepatobiliary Pathophysiology

GERD

Understanding the pathophysiology of gastroesophageal reflux disease and its clinical consequences.

A changing vital sign with DNA and microscope symbols for the study of disease processes.
Inside this lesson 10 sections 5 questions 5 figures

SECTION 1

Historical Context & Motivation

For centuries, symptoms of heartburn and acid regurgitation were dismissed as minor digestive complaints or attributed to dietary indiscretion. The recognition that chronic reflux of gastric contents into the esophagus constitutes a distinct disease entity—gastroesophageal reflux disease (GERD)—developed gradually over the twentieth century as advances in endoscopy, pH monitoring, and manometry revealed the structural and functional abnormalities underlying the condition. Today, GERD affects approximately 20% of the Western population and represents a significant burden on healthcare systems, making a thorough understanding of its pathophysiology essential for any healthcare professional.

1879 • Quincke Describes Esophageal Ulceration

Heinrich Quincke published the first clinical description of peptic esophageal ulceration, establishing that gastric acid could damage the esophageal mucosa—an observation that laid the groundwork for understanding reflux-related injury.

1935 • Winkelstein Links Acid to Esophagitis

Asher Winkelstein formally proposed that "peptic esophagitis" resulted from the prolonged contact of gastric hydrochloric acid with esophageal epithelium, shifting the paradigm from anatomical to chemical causation.

1956 • The Lower Esophageal Sphincter Identified

Fyke, Code, and Schlegel at the Mayo Clinic used intraluminal manometry to identify a zone of elevated resting pressure at the gastroesophageal junction—the lower esophageal sphincter (LES)—and demonstrated its role as an anti-reflux barrier.

1974 • Ambulatory pH Monitoring Introduced

Johnson and DeMeester pioneered prolonged ambulatory esophageal pH monitoring, enabling quantification of acid exposure over 24 hours and objective diagnosis of pathological reflux.

1990s • PPI Era and the Montreal Definition

The introduction of proton pump inhibitors transformed GERD management, and the 2006 Montreal Consensus formally defined GERD as "a condition which develops when the reflux of stomach contents causes troublesome symptoms and/or complications."

The central question that GERD pathophysiology addresses is deceptively simple: why does the physiological reflux that occurs transiently in healthy individuals become pathological in certain patients, leading to mucosal damage, metaplasia, and potentially adenocarcinoma? Answering this question requires an integrated understanding of anti-reflux barrier function, mucosal defense mechanisms, and the chemical composition of the refluxate.

SECTION 2

Core Principles & Definitions

GERD arises from a fundamental imbalance between aggressive factors (acid, pepsin, bile salts, and pancreatic enzymes in the refluxate) and defensive mechanisms (the anti-reflux barrier, esophageal clearance, and mucosal resistance). Understanding these core principles is critical to grasping why only a subset of individuals who experience reflux develop clinically significant disease. The following four foundational concepts organize the pathophysiology of GERD into a coherent framework.

1

Anti-Reflux Barrier Dysfunction

The lower esophageal sphincter (LES), the crural diaphragm, and the angle of His together form the anti-reflux barrier. Dysfunction of any component—especially transient LES relaxations (TLESRs)—permits retrograde flow of gastric contents.
2

Impaired Esophageal Clearance

Once refluxate enters the esophagus, volume clearance (peristalsis) and chemical clearance (salivary bicarbonate neutralization) determine contact time. Dysmotility or reduced salivation prolongs acid exposure.
3

Mucosal Resistance

The esophageal epithelium relies on pre-epithelial (mucus-bicarbonate layer), epithelial (tight junctions, intracellular buffers), and post-epithelial (blood flow supplying bicarbonate) defenses.
4

Refluxate Composition

The injurious potential of the refluxate depends on its chemical composition. While acid and pepsin are the primary offenders, bile acids and trypsin (in duodenogastroesophageal reflux) exert synergistic mucosal damage.
✦

KEY TAKEAWAY

Think of the gastroesophageal junction as a dam on a reservoir of acid. The dam has three components—the LES (the gate), the crural diaphragm (the embankment), and the angle of His (the spillway design). Physiological reflux is like water occasionally splashing over the top; GERD occurs when the dam is structurally weakened, the spillway angle is flattened (as in a hiatal hernia), or the gate opens spontaneously and too frequently (TLESRs). Once the acid "flood" enters the esophageal "valley," the speed at which it drains (peristalsis) and the neutralizing capacity of the soil (mucosal resistance) determine whether damage occurs.

SECTION 3

Visual Explanation — The Anti-Reflux Barrier

Anti-Reflux Barrier: Normal AnatomyEsophagealLumenLES (High Pressure Zone)CruralDiaphragmGastric Lumen(HCl, Pepsin, Bile)Resting LES tone:10–30 mmHgAngle of His(acute angle createsa flap valve)Three-Component BarrierLES intrinsic toneAngle of HisCrural diaphragm
The anti-reflux barrier consists of three synergistic components. The LES provides intrinsic smooth muscle tone (10–30 mmHg at rest). The angle of His creates a mucosal flap valve at the gastroesophageal junction. The crural diaphragm provides extrinsic compression that augments barrier pressure during inspiration and straining.

As the diagram illustrates, the gastroesophageal junction is not protected by a single sphincter but rather by a tripartite system in which each component reinforces the others. In the resting state, the LES maintains a tonic contraction that exceeds intragastric pressure, preventing retrograde flow. During inspiration, the crural diaphragm contracts around the distal esophagus, providing an additional external "clamp." The acute angle of His creates a mucosal rosette that acts as a flap valve—when intragastric pressure rises, the gastric fundus compresses this fold against the distal esophagus, further sealing the junction. A hiatal hernia disrupts this arrangement by displacing the LES above the diaphragmatic hiatus, thereby separating the intrinsic and extrinsic sphincter components and widening the angle of His, which fundamentally compromises the anti-reflux barrier.

SECTION 4

Pathophysiological Mechanisms

Transient Lower Esophageal Sphincter Relaxations (TLESRs)

The most common mechanism underlying GERD in patients without severe erosive disease is transient lower esophageal sphincter relaxation (TLESR). Unlike swallow-induced LES relaxation, TLESRs are vagally mediated reflexes triggered by gastric distension—particularly distension of the fundus—that cause complete, prolonged (>10 seconds) LES relaxation independent of any swallowing event. In healthy individuals, TLESRs serve as the mechanism for belching, occurring 3–6 times per hour postprandially. In GERD patients, TLESRs are not necessarily more frequent, but a significantly greater proportion of TLESRs are accompanied by acid reflux. The afferent limb of this reflex involves mechanoreceptors in the gastric cardia, the vagal afferent pathway to the brainstem nucleus tractus solitarius, and the efferent vagal pathway that releases nitric oxide and vasoactive intestinal peptide to relax the LES smooth muscle.

The Acid Pocket

A critical concept that bridges barrier dysfunction and refluxate composition is the acid pocket. Following a meal, the ingested food buffers the majority of gastric acid in the body of the stomach. However, a layer of newly secreted, unbuffered acid (pH < 2) accumulates at the gastric cardia, floating atop the chyme. This acid pocket, typically 2–3 cm in length, lies immediately below the gastroesophageal junction and serves as the reservoir from which refluxate is drawn during TLESRs. In patients with a hiatal hernia, the acid pocket migrates above the diaphragm to a supra-diaphragmatic position, placing it in direct contact with the squamocolumnar junction and dramatically increasing the likelihood that each TLESR event will deliver highly acidic refluxate to the distal esophagus.

Esophageal Clearance Mechanisms

Esophageal clearance occurs in two sequential phases. Volume clearance is achieved by primary and secondary peristalsis, which strips the bolus of refluxate back into the stomach. A single peristaltic sequence clears approximately 90% of the refluxed volume. Chemical clearance then neutralizes the residual thin film of acid through swallowed saliva, which contains bicarbonate at a concentration of approximately 7 mmol/L. Conditions that impair either phase—such as esophageal dysmotility (e.g., ineffective esophageal motility), xerostomia, or supine posture during sleep (which eliminates the gravitational component of clearance)—prolong mucosal acid contact time and increase the severity of reflux-related injury.

Pathophysiological Cascade of GERDBarrier Dysfunction↓LES tone, TLESRs,Hiatal herniaAcid PocketUnbuffered acid atgastric cardia (pH < 2)Impaired ClearanceDysmotility, ↓saliva,Supine postureProlonged Esophageal Acid ExposureAcid contact time exceeds mucosal defense capacityMucosal InjuryErosive esophagitisSymptom GenerationTRPV1, visceral hypersensitivityBarrett EsophagusIntestinal metaplasiaDysplasiaLow → High gradeAdenocarcinomaEsophageal cancerMetaplasia → Dysplasia → Carcinoma Sequence
The pathophysiological cascade of GERD begins with three converging factors—barrier dysfunction, the acid pocket, and impaired clearance—that together produce prolonged acid exposure. This leads to mucosal injury and symptom generation, with the potential for progression through the metaplasia–dysplasia–carcinoma sequence.

SECTION 5

Clinical Classification & Phenotypes

GERD is not a single disease but rather a spectrum of related phenotypes that differ in their clinical presentation, endoscopic findings, pathophysiology, and risk of complications. The modern classification recognizes three principal phenotypes, each requiring a nuanced understanding for appropriate management.

FeatureNon-Erosive Reflux Disease (NERD)Erosive Esophagitis (ERD)Barrett Esophagus (BE)
Prevalence~60–70% of GERD patients~25–35% of GERD patients~5–15% of GERD patients
Endoscopic FindingsNormal esophageal mucosaMucosal breaks (Los Angeles Grade A–D)Salmon-colored columnar mucosa replacing squamous epithelium
Primary MechanismVisceral hypersensitivity; microscopic mucosal changes; dilated intercellular spacesProlonged acid/pepsin contact; impaired mucosal defenseChronic acid and bile exposure driving intestinal metaplasia via CDX2 upregulation
Acid ExposureOften normal; symptom–reflux correlation importantAbnormal (pH < 4 for >4.2% of 24-hr period)Highest total acid exposure among GERD phenotypes
Cancer RiskNegligibleLow but increased vs. general population0.5–1% per year risk of esophageal adenocarcinoma

Clinical Phenotypes of GERD

The Los Angeles Classification of Erosive Esophagitis

The Los Angeles (LA) classification system is the standard grading system for erosive esophagitis and is based on the size and extent of mucosal breaks visible at endoscopy. Grade A involves one or more mucosal breaks no longer than 5 mm that do not extend between the tops of two mucosal folds. Grade B involves at least one mucosal break greater than 5 mm that does not extend between the tops of two mucosal folds. Grade C features at least one mucosal break that is continuous between the tops of two or more mucosal folds but involves less than 75% of the esophageal circumference. Grade D involves mucosal breaks encompassing at least 75% of the esophageal circumference. Grades C and D are considered clinically significant, representing severe erosive disease that warrants aggressive treatment and surveillance for complications.

ℹ

Clinical Pearl

The GERD phenotypes—NERD, ERD, and Barrett esophagus—are generally considered distinct entities rather than a continuous spectrum. Longitudinal studies show that most NERD patients do not progress to ERD over time, and the transition from ERD to Barrett esophagus occurs in a minority of cases. This has important implications: a patient presenting with NERD is unlikely to develop erosive disease even without treatment, whereas a patient with long-segment Barrett esophagus requires structured surveillance due to adenocarcinoma risk.

SECTION 6

Worked Example — Clinical Case Analysis

The following clinical scenario demonstrates how the pathophysiological principles of GERD integrate in a real patient presentation. This worked example walks through the process of identifying contributory factors, interpreting diagnostic data, and applying pathophysiological reasoning to explain the clinical picture.

Case: 52-Year-Old Male with Chronic Heartburn and Dysphagia

  1. 1

    Step 1 — Identify Clinical Presentation

    A 52-year-old obese male (BMI 34) presents with a 10-year history of heartburn occurring 4–5 times per week, nocturnal regurgitation, and recent-onset progressive dysphagia to solids. He has used over-the-counter antacids intermittently but has never received prescription acid suppression. Risk factors include central obesity, tobacco use, and a large evening meal followed by supine positioning within one hour.
  2. 2

    Step 2 — Analyze Pathophysiological Contributors

    Central obesity increases intra-abdominal pressure, promoting formation of a hiatal hernia and increasing the pressure gradient across the LES. This elevated pressure also increases the frequency of TLESRs by distending the gastric fundus. Tobacco use reduces LES tone by decreasing cholinergic stimulation and also reduces salivary bicarbonate secretion, impairing chemical clearance. Supine positioning after meals eliminates the gravitational component of esophageal clearance and allows the postprandial acid pocket to migrate toward the squamocolumnar junction.
    Multiple converging mechanisms: ↑TLESRs + ↓LES tone + ↓clearance = prolonged acid exposure
  3. 3

    Step 3 — Interpret Diagnostic Findings

    Upper endoscopy reveals a 3 cm sliding hiatal hernia, circumferential salmon-colored mucosa extending 4 cm proximal to the gastroesophageal junction, and a distal esophageal peptic stricture. Biopsies of the salmon-colored mucosa show intestinal metaplasia with goblet cells. Ambulatory 24-hour pH monitoring shows esophageal acid exposure (% time pH < 4) of 14.2% (normal < 4.2%), with a DeMeester score of 52 (normal < 14.7).
    Diagnosis: GERD complicated by long-segment Barrett esophagus and peptic stricture
  4. 4

    Step 4 — Apply Pathophysiological Reasoning to Complications

    The sliding hiatal hernia has separated the LES from the crural diaphragm, eliminating the extrinsic sphincter support and flattening the angle of His. Chronic, severe acid exposure (14.2% acid contact time—more than three times the upper limit of normal) has driven intestinal metaplasia, in which the normal stratified squamous epithelium is replaced by columnar epithelium with goblet cells. This metaplastic change represents an adaptive but precancerous response: columnar epithelium with its mucus-secreting goblet cells is more resistant to acid injury than squamous epithelium, but the molecular reprogramming—mediated by transcription factors such as CDX2—creates a cellular environment susceptible to dysplastic transformation. The peptic stricture formed through a cycle of inflammation, submucosal fibrosis, and collagen deposition, explaining the patient's dysphagia.
    Complications explained: Hiatal hernia → severe acid exposure → metaplasia (Barrett) + fibrosis (stricture)

SECTION 7

Diagnostic Modalities & Management Approaches

Accurate diagnosis and evidence-based management of GERD require an understanding of both the strengths and limitations of available diagnostic tools and therapeutic strategies. The following table compares the principal diagnostic modalities, while the subsequent discussion contextualizes their application in clinical practice.

Diagnostic ModalityStrengthsLimitations
PPI Trial (Empirical)Non-invasive; inexpensive; high sensitivity (~80%) for acid-related GERD; widely accessibleLow specificity (~50%); positive response may reflect placebo or non-GERD acid disorders; does not evaluate complications
Upper Endoscopy (EGD)Directly visualizes mucosa; identifies erosions, Barrett, strictures; allows biopsy; gold standard for complicationsNormal in 60–70% of GERD patients (NERD); does not quantify reflux burden; invasive; requires sedation
Ambulatory pH MonitoringQuantifies acid exposure objectively; establishes symptom–reflux correlation (symptom index, SAP); available as catheter-based or wireless (Bravo)Does not detect non-acid or weakly acidic reflux; catheter discomfort may reduce normal behavior; single-day testing may miss intermittent reflux
pH-Impedance MonitoringDetects acid, weakly acidic, and non-acid reflux; measures bolus height and clearance; most comprehensive reflux assessmentRequires specialized equipment and expertise; catheter-based; normative data still evolving; higher cost
High-Resolution ManometryEvaluates LES pressure and relaxation; identifies esophageal dysmotility; essential pre-operative evaluation for anti-reflux surgeryDoes not measure reflux directly; primarily used to exclude motility disorders; does not confirm GERD diagnosis

Comparison of GERD Diagnostic Modalities

✦

KEY TAKEAWAY

No single diagnostic test is sufficient to characterize GERD in all patients. The clinical approach is stepwise: begin with an empirical PPI trial for typical symptoms without alarm features, proceed to endoscopy when alarm features (dysphagia, weight loss, GI bleeding) are present or symptoms are refractory, and reserve ambulatory reflux monitoring for patients with persistent symptoms despite therapy or those being considered for anti-reflux surgery. Think of it as a diagnostic funnel—each test adds a layer of specificity, from symptom-based screening to objective physiological measurement.

SECTION 8

Complications & Advanced Concepts

While the majority of GERD patients experience a benign, symptom-driven disease course, a subset develops significant complications that reflect the progressive nature of chronic acid-mediated injury. Understanding the pathophysiological basis of these complications is essential for risk stratification, surveillance, and timely intervention. Furthermore, emerging research into the role of mucosal immune activation, the esophageal microbiome, and neural hypersensitivity is expanding the conceptual framework of GERD beyond a simple acid-contact model.

ConceptTraditional UnderstandingEmerging/Advanced Perspective
Mucosal InjuryDirect chemical burn by acid/pepsin causing surface erosion ("outside-in" injury)Cytokine-mediated inflammation (IL-8, IL-1β) triggered by acid penetration into intercellular spaces, causing basal cell proliferation and "inside-out" injury pattern
Barrett PathogenesisSimple replacement of damaged squamous cells by columnar cells from the gastric cardiaReprogramming of esophageal stem/progenitor cells via Wnt, Notch, BMP, and Hedgehog signaling; CDX2 transcription factor as the master regulator of intestinalization
Symptom GenerationHeartburn from acid irritation of sensory nerve endingsTRPV1 and ASIC receptor upregulation; peripheral and central sensitization; role of weakly acidic and non-acid reflux in refractory symptoms
Extra-esophageal GERDAcid directly contacts larynx/pharynx/airway (micro-aspiration)Vagally mediated reflex bronchospasm (esophageal-bronchial reflex); inflammatory mediators from distal esophageal acid exposure trigger airway hyperreactivity without direct aspiration

Traditional vs. Emerging Perspectives in GERD

These evolving concepts have significant clinical implications. The recognition that reflux-induced esophagitis may be driven by cytokine-mediated inflammation rather than purely chemical corrosion opens the door for targeted anti-inflammatory therapies. The discovery that symptom perception in NERD is closely linked to visceral hypersensitivity and central pain processing explains why some patients remain symptomatic despite adequate acid suppression and suggests a role for neuromodulators such as tricyclic antidepressants or SSRIs in refractory cases. Students pursuing advanced study in gastroenterology, oncology, or pharmacology will encounter these concepts as active areas of translational research.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

A healthy volunteer undergoes 24-hour ambulatory pH monitoring and is found to have transient episodes of esophageal pH < 4, primarily in the postprandial period. Does this represent GERD? Explain the distinction between physiological and pathological reflux using the concept of the anti-reflux barrier.
Show answer
This does not represent GERD. Physiological reflux occurs in virtually all healthy individuals, particularly postprandially, when gastric distension triggers transient lower esophageal sphincter relaxations (TLESRs) that serve as the venting mechanism for swallowed air. In healthy subjects, the total esophageal acid exposure time remains below the pathological threshold (typically < 4.2% of the total monitoring period with pH < 4). Pathological reflux occurs when the anti-reflux barrier is compromised—through hypotensive LES, hiatal hernia, or an increased proportion of TLESRs accompanied by acid—resulting in acid exposure that exceeds the esophageal mucosa's capacity for clearance and repair. GERD is defined by the Montreal Consensus as the condition in which reflux causes troublesome symptoms and/or complications, not merely by the presence of reflux episodes.

Question 2: BASIC CALCULATION

A patient undergoes 24-hour ambulatory pH monitoring. The probe records a total of 1,440 minutes (24 hours). The cumulative time with esophageal pH < 4 is 86.4 minutes. Calculate the percentage acid exposure time and determine whether it falls within the pathological range (threshold: >4.2%).
Show answer
Percent acid exposure time = (time with pH < 4 ÷ total monitoring time) × 100 = (86.4 ÷ 1,440) × 100 = 6.0%. This value of 6.0% exceeds the upper limit of normal (4.2%) and is therefore within the pathological range, supporting a diagnosis of abnormal esophageal acid exposure. This calculation is the foundation of the DeMeester score, which incorporates six additional parameters (number of reflux episodes, number of episodes >5 minutes, longest episode duration, upright and supine acid exposure) to generate a composite reflux index. A DeMeester score >14.7 is considered abnormal.

Question 3: INTERMEDIATE

A 45-year-old woman with GERD undergoes high-resolution manometry that reveals an LES resting pressure of 4 mmHg (normal: 10–30 mmHg) and 40% ineffective swallows (normal: <30%). She also has a 4 cm sliding hiatal hernia. Using these data, explain which components of the anti-reflux barrier are compromised and predict how this would affect both volume and chemical clearance.
Show answer
This patient has compromise of all three components of the anti-reflux barrier. The hypotensive LES (4 mmHg, well below the normal minimum of 10 mmHg) means the intrinsic sphincter is unable to maintain adequate resting tone against the positive abdominal-to-thoracic pressure gradient. The 4 cm sliding hiatal hernia displaces the LES above the diaphragmatic hiatus, separating it from the crural diaphragm (the extrinsic sphincter component) and blunting the angle of His. The 40% rate of ineffective swallows directly impairs volume clearance: with nearly half of peristaltic sequences failing to generate adequate contraction amplitude, the refluxed bolus is not efficiently stripped from the esophageal lumen. Volume clearance failure prolongs the contact time of the residual acid film with the mucosa, and since chemical clearance depends on the thin remaining film being neutralized by swallowed saliva, the cumulative effect is dramatically prolonged acid exposure time.

Question 4: APPLIED

A 60-year-old male with a 20-year history of GERD undergoes surveillance endoscopy that reveals a long-segment (5 cm) area of salmon-colored mucosa at the gastroesophageal junction. Biopsies confirm intestinal metaplasia with goblet cells but no dysplasia. Explain the pathophysiological sequence that led to this finding, identify the transcription factor most directly responsible for intestinal metaplasia, and describe the clinical significance of this finding in terms of cancer risk and recommended surveillance intervals.
Show answer
This patient has developed long-segment Barrett esophagus as a consequence of chronic, severe esophageal acid (and likely bile) exposure. The pathophysiological sequence is as follows: chronic reflux causes repeated cycles of mucosal injury and repair in the distal esophagus. Over time, the normal stratified squamous epithelium is replaced by specialized intestinal-type columnar epithelium—a process known as intestinal metaplasia. This metaplastic transformation is driven primarily by upregulation of the CDX2 transcription factor, a homeobox gene normally expressed in intestinal epithelium that, when activated in esophageal progenitor cells by chronic acid and bile exposure, reprograms cellular differentiation toward an intestinal phenotype including goblet cell formation. The clinical significance is that Barrett esophagus is the only known precursor to esophageal adenocarcinoma, with an annual progression rate to cancer of approximately 0.5–1% per year. Current guidelines recommend endoscopic surveillance every 3–5 years for Barrett esophagus without dysplasia, with shorter intervals (6–12 months) if low-grade dysplasia is detected.

Question 5: CRITICAL THINKING

A patient with typical GERD symptoms (heartburn and regurgitation) fails to improve after an 8-week trial of twice-daily proton pump inhibitor therapy. Upper endoscopy is normal, and ambulatory pH-impedance monitoring performed ON PPI therapy shows normal acid exposure (2.1%) but 73 weakly acidic reflux episodes per 24 hours (normal < 54), with a positive symptom association probability (SAP > 95%) for weakly acidic events. Using your knowledge of GERD pathophysiology, explain why this patient is symptomatic despite adequate acid suppression, discuss the concept of visceral hypersensitivity in this context, and propose a mechanistic rationale for a potential therapeutic approach.
Show answer
This patient demonstrates PPI-refractory GERD driven by weakly acidic reflux events with a positive symptom association, indicating that symptoms are generated by refluxate with pH > 4 that is not suppressed by PPIs. PPIs reduce acid secretion by irreversibly inhibiting the H⁺/K⁺-ATPase proton pump but do not reduce the total number of reflux episodes or alter the mechanical incompetence of the anti-reflux barrier. Weakly acidic reflux can trigger symptoms through several mechanisms: mechanical distension of the esophageal wall activates mechanoreceptors; bile salts in the refluxate can stimulate TRPV1 receptors independently of acid; and upregulated acid-sensing ion channels (ASICs) lower the threshold for symptom perception. The concept of visceral hypersensitivity is central here—peripheral sensitization involves upregulation of nociceptive receptors (TRPV1, ASIC) in the esophageal mucosa following chronic acid exposure, while central sensitization involves amplification of afferent signaling at the level of the dorsal horn and brain, effectively "lowering the volume control" for pain perception. A mechanistic therapeutic approach could include baclofen (a GABA-B agonist that reduces TLESRs by approximately 40%), neuromodulators such as low-dose tricyclic antidepressants that modulate central pain processing, or surgical fundoplication, which mechanically restores the anti-reflux barrier and reduces both acid and non-acid reflux episodes regardless of refluxate pH.

SUMMARY

Summary

Summary

Gastroesophageal reflux disease (GERD) results from an imbalance between aggressive factors (acid, pepsin, bile) and defensive mechanisms at the gastroesophageal junction. The anti-reflux barrier comprises three components—the lower esophageal sphincter (LES), the crural diaphragm, and the angle of His—and the most common mechanism of reflux is transient LES relaxation (TLESR). The postprandial acid pocket serves as the reservoir for refluxate, and its position relative to the diaphragm is modified by the presence of a hiatal hernia.

GERD manifests as three clinical phenotypes—non-erosive reflux disease (NERD), erosive esophagitis (ERD), and Barrett esophagus—that differ in pathophysiology, endoscopic findings, and cancer risk. The Los Angeles classification grades erosive disease severity. Diagnosis employs a stepwise approach from empirical PPI trial to endoscopy and ambulatory reflux monitoring. Emerging concepts including visceral hypersensitivity, cytokine-mediated "inside-out" injury, and weakly acidic reflux are reshaping our understanding of refractory disease and driving the development of novel therapeutic strategies beyond acid suppression.

Varsity Tutors • Pathophysiology • GERD